MedPath

Glycemic index and blood glucose response of nutritional products in overweight/obese subjects

Not Applicable
Registration Number
CTRI/2020/04/024475
Lead Sponsor
Dr Reddys Laboratories Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Males and/or Female subject with the age group 18 to 60 years.

2.The subject should be overweight/ obese with a Body mass index (BMI) in the range of 23-33 kg/m2

(Asian Indian specific cut offs)

3. The subject should be willing to refrain from smoking, alcohol and caffeine containing drinks during the study period.

4. The subject should be willing to comply with study protocol requirements including adherence to diet and lifestyle modifications.

5. The subject should be willing to provide a written informed consent.

Exclusion Criteria

1. Diabetic Individual, type I/II diabetics, Gestational Diabetes

2.Subject taking Metformin

3. Subject who has been diagnosed to have acute infections like viral fever, typhoid, cold, diarrhoea within one month prior to enrolment.

4.Subject with complications such as respiratory disorders, cancer or heart attack and stroke

5. History of malignancy in the past 1 year.

6.Having any eating disorder or Lactose intolerance

7.History of hypoglycaemia in last 3 months

8.Taking any herbal/Ayurveda/Traditional preparation that could profoundly affect blood glucose

9.Pregnant and lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determination of glycemic index value of high protein high fiber nutritional product in comparison to standard glucose solutionTimepoint: Blood sugar will be measured at specific time points over the next three hours i.e. 0, 15, 30, 45, 60, 90, 120 and 150 minutes (±5 minutes window period)
Secondary Outcome Measures
NameTimeMethod
Blood glucose response (Cmax) and time for peak plasma concentration (Tmax) of high protein high fiber nutritional product in comparison to standard glucose solutionTimepoint: Blood sugar will be measured at specific time points over the next three hours i.e. 0, 15, 30, 45, 60, 90, 120 and 150 minutes (±5 minutes window period);Determination of glucose response value of high protein high fiber nutritional product in comparison to standard glucose solution (IAUC)Timepoint: Blood sugar will be measured at specific time points over the next three hours i.e. 0, 15, 30, 45, 60, 90, 120 and 150 minutes (±5 minutes window period);Incidence of Adverse Event (AE) and Serious Adverse Events (SAEs) during the study periodTimepoint: Throughout the study
© Copyright 2025. All Rights Reserved by MedPath